Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v6-EN
Language French English
Date Updated 2018-03-13 2017-10-10
Drug Identification Number 02413825 02413825
Brand name TEVA-VALGANCICLOVIR TEVA-VALGANCICLOVIR
Common or Proper name VALGANCICLOVIR VALGANCICLOVIR
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients VALGANCICLOVIR VALGANCICLOVIR
Strength(s) 450MG 450MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60 60
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-08-01 2017-08-01
Estimated end date 2018-02-16 2018-01-25
Actual end date 2018-02-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments